Zonsen PepLib Biotech Inc.
ZhuZhou, China peplib.com From their website, Nov 2026
Work here? Claim this listing
About
Zonsen PepLib Biotech Inc. is a biotechnology company focused on discovering and developing peptide-based therapeutics. It is headquartered in Zhuzhou, China, with operations in Changsha, China, and a subsidiary in New Jersey, USA. Its work centers on oncology and cardiometabolic diseases and supports multiple peptide-based modalities.
Services
Peptide-radionuclide conjugate (PRC) discovery and development
Supports PRC peptide screening and design, in-vitro study, in-vivo study, and IIT study collaboration.
Peptide screening and design
Uses DRP-PD, AI, mRNA display, and med-chem for PRC-peptide screening and design.
Medicinal chemistry optimization
Optimizes hits to leads for peptide-radionuclide conjugate development.
High-throughput screening assay
Provides high-throughput screening support for peptide discovery programs.
Protein expression and purification
Offers protein expression and purification capability as a technology platform.
Protein production
Cell-line generation
Provides cell-line generation for research and development work.
Gene construction and peptide expression
Supports gene construction and peptide expression workflows.
In vitro BBB penetration assay
Offers in vitro blood-brain barrier penetration testing.
5 more services
- 3D cell generation for pharmacodynamic measurement
- Peptide-chip array screening
- Conjugation and linker chemistry optimization
- Computational structural analysis and bioinformatics
- ADME Met-ID
- Turnaround
- 2-4 months
Capabilities
- Assays and studies
- Peptides
- Oligonucleotides
- mRNA
- HTS
- ADME
- High-throughput screening
7 more
- In-vitro study
- In-vivo study
- IIT study
- BBB penetration assay
- Peptide-chip array screening
- ADME Met-ID
- Pharmacodynamic measurement
- Scale and capacity
- Nearly 500 million peptides in the database
- More than 300 people
- Therapeutic areas
- Oncology
- Cardiometabolic diseases
Instruments and platforms
- AI Platform
Modalities and species
- Modalities
- Peptide
- Oligonucleotide
- mRNA
- Species and models
- mRNA Display
- DRP-PD Library
- 3D cell
Company
- Founded
- 2017
- Team
- More than 300 people
- Quality
- PCT applications
Locations
- Address
- 1769 Yunlong Avenue, Yunlong Demonstration Zone, Zhuzhou, Hunan Province Submit Message C
- Sites
- Changsha, China
- New Jersey, USA
- Metuchen, NJ, USA
- Serves
- Worldwide, China